浙江尖峰集团股份有限公司2025年年度业绩预告

Core Viewpoint - Zhejiang Jianfeng Group Co., Ltd. anticipates a significant increase in net profit for the year 2025, while also forecasting a substantial decrease in net profit after excluding non-recurring gains [2][4]. Group 1: Performance Forecast - The company expects to achieve a net profit attributable to shareholders of approximately 460 million yuan for the year 2025, representing an increase of about 352.01 million yuan, or 325.97% compared to the previous year [2][4]. - The forecasted net profit attributable to shareholders after excluding non-recurring gains is approximately -215 million yuan, indicating a decrease of about 311.62 million yuan, or 322.53% year-on-year [2][4]. Group 2: Previous Year Performance - In the previous year, the total profit was approximately 201.20 million yuan, with a net profit attributable to shareholders of about 107.99 million yuan, and a net profit after excluding non-recurring gains of approximately 96.62 million yuan [6]. Group 3: Reasons for Performance Changes - The significant increase in net profit is primarily due to the equity method accounting for Tian Shili Biological Pharmaceutical Industry Group Co., Ltd., which sold its equity assets, resulting in substantial non-recurring gains [8]. - The decrease in net profit after excluding non-recurring gains is attributed to reduced demand in the cement industry and declining prices and sales in the pharmaceutical sector, influenced by policies such as drug procurement and price reductions [9][10].